4 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $33M | $4M | 25.1% | 23.6% | -$14M | — | $1M |
| 2024 | $26M | $3M | 25.4% | 21.7% | -$4M | $3M | $170431 |
| 2023 | $27M | $4M | 25.7% | 22.5% | $921339 | $3M | $86287 |
| 2022 | $29M | $4M | 26.7% | 21.4% | -$500620 | — | — |
How the market has priced HXHX against its own fundamentals since 2025-04 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 3 years, Haoxin Holdings Ltd's revenue has grown 4.5% per year, and net income declined 2.5% per year. These are computed facts, not advice.
As of FY2025, Haoxin Holdings Ltd reported — of total debt against $1M of cash; operating income covered interest expense 29×.
In FY2025, gross margin was 25.1%, operating margin 23.6%, and net margin 12.0%.
As of Jun '26, Haoxin Holdings Ltd traded at a price-to-earnings ratio of about 1.4× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.